Mariner, LLC Guardant Health, Inc. Transaction History

Mariner, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$21.58 - $29.5 $288,826 - $394,828	13,384 New	13,384 $362,000
Q2 2023 Aug 11, 2023	BUY	$20.94 - $38.01 $125,640 - $228,060	6,000 Added 54.61%	16,987 $608,000
Q1 2023 May 12, 2023	BUY	$22.92 - $33.76 $251,822 - $370,921	10,987 New	10,987 $258,000
Q3 2022 Nov 10, 2022	BUY	$43.66 - $61.0 $232,314 - $324,581	5,321 New	5,321 $286,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.